Drugs / B-3E07
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07497503 | Apr → Sep 2026 overdue | — | Syneos Health | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B-3E07 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07497503 ↗ |
| Route | Subcutaneous | “B-3E07 will be administered as SC injection.” NCT07497503 ↗ |